Enhancing immune regulation in vitro: the synergistic impact of 3′-sialyllactose and osteopontin in a nutrient blend following influenza virus infection

Enhancing immune regulation in vitro: the synergistic impact of 3′-sialyllactose and osteopontin in a nutrient blend following influenza virus infection

Natural components of breast milk, human milk oligosaccharides (HMOs) and osteopontin (OPN) have been shown to have a variety of functional activities and are widely used in infant formulas. However, the preventive and therapeutic effects of both on influenza viruses are not known. In this study, an...

Full description

Bibliographic Details
Main Authors:	Zhengtao Guo, Qinggang Xie, Qiqi Ren, Yang Liu, Kaifeng Li, Bailiang Li, Jufang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	3′-sialyllactose osteopontin influenza virus immune cytokines human milk oligosaccharide
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1271926/full

Similar Items

Human milk oligosaccharides 3′-sialyllactose and 6′-sialyllactose protect intestine against necrotizing enterocolitis damage induced by hypoxia
by: Ziyu Huang, et al.
Published: (2021-11-01)

Sialyllactose Enhances the Short-Chain Fatty Acid Production and Barrier Function of Gut Epithelial Cells via Nonbifidogenic Modification of the Fecal Microbiome in Human Adults
by: Yohei Sato, et al.
Published: (2024-01-01)

Evaluation of 6′-Sialyllactose Sodium Salt Supplementation to Formula on Growth and Clinical Parameters in Neonatal Piglets
by: Marcia H. Monaco, et al.
Published: (2020-04-01)

Multivalent Sialyllactose-Levan-Conjugated Gold Nanoparticles for Efficient Interaction with and Colorimetric Detection of Influenza A Virus
by: Sun-Jung Kim, et al.
Published: (2021-07-01)

Dietary supplementation of 3′-sialyllactose or 6′-sialyllactose elicits minimal influence on cognitive and brain development in growing pigs
by: Rebecca K. Golden, et al.
Published: (2024-01-01)

Safety of 6′‐Sialyllactose (6′‐SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2020-05-01)

Determining the safety and efficacy of dietary supplementation with 3ˊ-sialyllactose or 6ˊ-sialyllactose on growth, tolerance, and brain sialic acid concentrations
by: Rebecca K. Golden, et al.
Published: (2023-10-01)

3′sialyllactose and 6′sialyllactose enhance performance in endurance‐type exercise through metabolic adaptation
by: Jesus Arellano Spadaro, et al.
Published: (2023-10-01)

Safety of 3′‐sialyllactose (3′‐SL) sodium salt produced by a derivative strain (Escherichia coli NEO3) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-09-01)

Exposure to 3′Sialyllactose-Poor Milk during Lactation Impairs Cognitive Capabilities in Adulthood
by: Edoardo Pisa, et al.
Published: (2021-11-01)

Safety of 6′‐sialyllactose (6′‐SL) sodium salt produced by a derivative strain (Escherichia coli NEO6) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-06-01)

Safety of 3’‐sialyllactose (3’‐SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2022-05-01)

Safety of 6′‐sialyllactose (6’‐SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2022-12-01)

Anti-Angiogenic Property of Free Human Oligosaccharides
by: Boram Bae, et al.
Published: (2021-05-01)

The Protective and Long-Lasting Effects of Human Milk Oligosaccharides on Cognition in Mammals
by: Sylvia Docq, et al.
Published: (2020-11-01)

Determination of 3′-Sialyllactose in Edible Bird’s Nests and the Effect of Stewing Conditions on the 3′-Sialyllactose Content of Edible Bird’s Nest Products
by: Xiaojiang Zhang, et al.
Published: (2023-02-01)

6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
by: Tawfik Abou Assale, et al.
Published: (2023-12-01)

Total Osteopontin and Its Isoform OPN4 Are Differently Expressed in Respiratory Samples during Influenza A(H1N1)pdm09 Infection and Progression
by: Jéssica Santa Cruz de Carvalho Martins, et al.
Published: (2023-05-01)

Effect of sialyllactose on growth performance and intestinal epithelium functions in weaned pigs challenged by enterotoxigenic Escherichia Coli
by: Qiming Duan, et al.
Published: (2022-03-01)

Human Milk Oligosaccharides in Cord Blood Are Altered in Gestational Diabetes and Stimulate Feto-Placental Angiogenesis In Vitro
by: Denise Hoch, et al.
Published: (2021-11-01)

Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases
by: Marit Zuurveld, et al.
Published: (2020-05-01)

Bifidobacterium mongoliense genome seems particularly adapted to milk oligosaccharide digestion leading to production of antivirulent metabolites
by: Pauline Bondue, et al.
Published: (2020-05-01)

Pharmacokinetics and clinical efficacy of 6′-sialyllactose in patients with GNE myopathy: Randomized pilot trial
by: Young-Eun Park, et al.
Published: (2023-12-01)

Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro
by: Olaf Perdijk, et al.
Published: (2019-02-01)

Corrigendum: Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro
by: Olaf Perdijk, et al.
Published: (2019-04-01)

3′-Sialyllactose Protects SW1353 Chondrocytic Cells From Interleukin-1β-Induced Oxidative Stress and Inflammation
by: Ahreum Baek, et al.
Published: (2021-04-01)

The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles
by: Ana Clara Santos da Fonseca Bastos, et al.
Published: (2023-02-01)

Longitudinal changes of lactopontin (milk osteopontin) in term and preterm human milk
by: Jing Zhu, et al.
Published: (2022-07-01)

Protein engineering of CMP kinases to improve thermal stability and resultant production of 3′-sialyllactose
by: Jingjing Wang, et al.
Published: (2022-12-01)

The levels of osteopontin in human milk of Chinese mothers and its associations with maternal body composition
by: Huijuan Ruan, et al.
Published: (2022-09-01)

Simultaneous Quantification of 3′- and 6′-Sialyllactose in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study
by: Seok-In Jang, et al.
Published: (2021-02-01)

Development and Validation of a Bioanalytical Method for 3′- and 6′-Sialyllactose in Minipig Liver and Kidney Using Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Analysis of Tissue Distribution
by: Han Young Eom, et al.
Published: (2020-12-01)

Milk Osteopontin and Human Health
by: Esben S. Sørensen, et al.
Published: (2023-05-01)

Bovine milk osteopontin improved intestinal health of pregnant rats fed a high-fat diet through improving bile acid metabolism
by: Lihua Han, et al.
Published: (2024-01-01)

Osteopontin expression in reactive lesions of gingiva
by: Rathinam ELANAGAI, et al.
Published: (2015-02-01)

Osteopontin Levels in Human Milk Are Related to Maternal Nutrition and Infant Health and Growth
by: Aysegül Aksan, et al.
Published: (2021-07-01)

Immunoregulatory Roles of Osteopontin in Diseases
by: Lebei Wang, et al.
Published: (2024-01-01)

A Reversed-Phase HPLC Method for Determination of Osteopontin in Infant Formula
by: Md Abdul Wazed, et al.
Published: (2019-09-01)

Osteopontin in Cardiovascular Diseases
by: Kohsuke Shirakawa, et al.
Published: (2021-07-01)

Human Milk Oligosaccharide Supplementation Affects Intestinal Barrier Function and Microbial Composition in the Gastrointestinal Tract of Young Sprague Dawley Rats
by: Faye Chleilat, et al.
Published: (2020-05-01)